Invitation to presentation of BioArctic's first quarter report for January - March 2025 on May 21 at 9.30 a.m. CET
BioArctic AB (Nasdaq Stockholm: BIOA B) has announced it will release its Q1 2025 financial report on Wednesday, May 21, 2025, at 08:00 CET. Following the report's publication, the company will host an audiocast with teleconference in English at 09:30 CET.
CEO Gunilla Osswald and CFO Anders Martin-Löf will present the quarterly results and conduct a Q&A session. Participants can join via webcast or teleconference, with options for submitting questions either in writing through the webcast or verbally via the teleconference. The presentation will later be available on-demand through BioArctic's corporate website.
BioArctic AB (Nasdaq Stoccolma: BIOA B) ha annunciato che pubblicherà il suo rapporto finanziario del primo trimestre 2025 mercoledì 21 maggio 2025 alle ore 08:00 CET. Dopo la pubblicazione del rapporto, l'azienda terrà una audioconferenza in inglese alle 09:30 CET.
La CEO Gunilla Osswald e il CFO Anders Martin-Löf presenteranno i risultati trimestrali e condurranno una sessione di domande e risposte. I partecipanti potranno collegarsi tramite webcast o teleconferenza, con la possibilità di inviare domande sia per iscritto tramite il webcast sia verbalmente durante la teleconferenza. La presentazione sarà poi disponibile on-demand sul sito web aziendale di BioArctic.
BioArctic AB (Nasdaq Estocolmo: BIOA B) ha anunciado que publicará su informe financiero del primer trimestre de 2025 el miércoles 21 de mayo de 2025 a las 08:00 CET. Tras la publicación del informe, la compañía realizará una audioconferencia en inglés a las 09:30 CET.
La CEO Gunilla Osswald y el CFO Anders Martin-Löf presentarán los resultados trimestrales y llevarán a cabo una sesión de preguntas y respuestas. Los participantes podrán unirse mediante webcast o teleconferencia, con opciones para enviar preguntas por escrito a través del webcast o verbalmente durante la teleconferencia. La presentación estará disponible posteriormente bajo demanda en el sitio web corporativo de BioArctic.
BioArctic AB (나스닥 스톡홀름: BIOA B)는 2025년 1분기 재무 보고서를 2025년 5월 21일 수요일 오전 08:00 CET에 발표할 예정이라고 발표했습니다. 보고서 발표 후, 회사는 09:30 CET에 영어로 오디오캐스트 및 전화 회의를 진행합니다.
CEO Gunilla Osswald와 CFO Anders Martin-Löf가 분기 실적을 발표하고 질의응답 시간을 가질 예정입니다. 참가자들은 웹캐스트 또는 전화 회의를 통해 참여할 수 있으며, 질문은 웹캐스트를 통한 서면 제출 또는 전화 회의 중 구두 제출이 가능합니다. 발표 내용은 이후 BioArctic 공식 웹사이트에서 온디맨드로 제공됩니다.
BioArctic AB (Nasdaq Stockholm : BIOA B) a annoncé qu'elle publiera son rapport financier du premier trimestre 2025 le mercredi 21 mai 2025 à 08h00 CET. Après la publication du rapport, la société organisera une audioconférence en anglais à 09h30 CET.
La PDG Gunilla Osswald et le directeur financier Anders Martin-Löf présenteront les résultats trimestriels et animeront une session de questions-réponses. Les participants pourront se joindre via webcast ou téléconférence, avec la possibilité de poser des questions par écrit via le webcast ou oralement lors de la téléconférence. La présentation sera ensuite disponible en replay sur le site corporate de BioArctic.
BioArctic AB (Nasdaq Stockholm: BIOA B) hat angekündigt, dass es seinen Finanzbericht für das erste Quartal 2025 am Mittwoch, den 21. Mai 2025, um 08:00 Uhr MEZ veröffentlichen wird. Im Anschluss an die Veröffentlichung wird das Unternehmen um 09:30 Uhr MEZ eine Audiokonferenz auf Englisch abhalten.
CEO Gunilla Osswald und CFO Anders Martin-Löf werden die Quartalsergebnisse präsentieren und eine Fragerunde durchführen. Teilnehmer können per Webcast oder Telefonkonferenz teilnehmen und Fragen entweder schriftlich über den Webcast oder mündlich über die Telefonkonferenz stellen. Die Präsentation wird später auf Abruf über die Unternehmenswebsite von BioArctic verfügbar sein.
- None.
- None.
In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on May 21, at 09:30 CET, where Gunilla Osswald, CEO, and Anders Martin-Löf, CFO, will present and comment on the first quarter report, followed by a Q&A-session.
If you wish to participate via webcast, please use the link below. Via the webcast you will be able to ask written questions.
Webcast: https://bioarctic.events.inderes.com/q1-report-2025/register
If you wish to participate via teleconference, please register on the link below. After registration you will be provided with phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.
https://events.inderes.com/bioarctic/q1-report-2025/dial-in
The webcast will also be available on demand on BioArctic's corporate website https://www.bioarctic.com/en/investors/financial-reports-and-presentations/ after the presentation.
---
For more information, please contact:
Anders Martin-Löf, CFO
Phone: +46 70 683 79 77
E-mail: anders.martin-lof@bioarctic.com
This information was submitted for publication at 08:30 a.m. CET on May 13, 2025.
About BioArctic AB
BioArctic AB (publ) is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. The company is the originator of Leqembi® (lecanemab) – the world's first drug proven to slow the progression of the disease and reduce cognitive impairment in early Alzheimer's disease. Leqembi has been developed together with Eisai. BioArctic has a broad research portfolio within Alzheimer's disease, Parkinson's disease, ALS and enzyme deficiency diseases. Several of the projects utilize the company's proprietary BrainTransporter™ technology, which improves the transport of drugs into the brain. BioArctic's B share (BIOA B) is listed on Nasdaq Stockholm Large Cap. For more information, please visit www.bioarctic.com.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Invitation to presentation of BioArctic’s first quarter report for January - March 2025 |
View original content:https://www.prnewswire.com/news-releases/invitation-to-presentation-of-bioarctics-first-quarter-report-for-january---march-2025-on-may-21-at-9-30-am-cet-302453502.html
SOURCE BioArctic
FAQ
When will BioArctic (BIOA) release its Q1 2025 earnings report?
How can I participate in BioArctic's Q1 2025 earnings call?
Who will present BioArctic's Q1 2025 earnings results?
Where can I find BioArctic's Q1 2025 earnings presentation after the event?
